Deborah is founder and Chief Executive Officer of NovaBiotics, a biotechnology business with a portfolio of first-in-class solutions for unmet health and personal care needs.
Deborah chairs the boards of Opportunity North East (ONE) Life Science and BioAberdeen Ltd., is a member of the Scottish Life Sciences Industry Leadership Group and chairs the UK’s Cystic Fibrosis AMR Syndicate steering group. Deborah also serves on and chairs a number of scientific advisory boards including Pathways to Antimicrobial Clinical Efficacy (PACE) and the CF AMR Collaborative Discovery programme (CDP).
Deborah obtained her PhD in immunology from UCL and then worked in postdoctoral positions in San Diego, Ghent and Aberdeen. Elected as a Fellow of the Royal Society of Edinburgh in 2018, Deborah is also a Fellow of the Royal Society of Medicine and in 2020, was awarded an OBE, for services to biotechnology, industry and charity.